Skip to main content

'Give It a Shot’: Documentary chronicles an Indian breakthrough in male contraception

By Ankur Shah* 
One of the perks of living in Los Angeles seems to be the opportunity to attend early screenings of films. Recently, I watched a documentary feature about a breakthrough at the intersection of gender equity, healthcare and bioelectric engineering. The film traces the story of a remarkable Indian innovation, supported by significant clinical data, based on a technology first published in 1979 by its inventor, Dr. Sujoy Guha, and his colleagues.
As a young biomedical engineering student in 2013, I attended a lecture by Dr. Guha. He was introduced to us as one of India's first biomedical engineers and a pioneer in bioengineering for reproductive medicine. For me, he was the first person I had heard speak about applying bioelectric phenomena in medical technology. The idea caught my attention and clearly left a lasting impression. I am still a researcher in bioelectricity and an enthusiast of medical technology. Interestingly, the technology itself is precisely that: a bioelectric solution to a medical challenge.
Briefly, the technology, known as RISUG (Reversible Inhibition of Sperm Under Guidance), involves injecting a hydrogel into the vas deferens, the tube that carries sperm. In a conventional vasectomy, this tube is cut or blocked. The hydrogel creates electrical and pH-related stress that damages or disables sperm cells as they pass through it, thereby preventing fertilisation. The gel can also be flushed out using specific solvents, making the procedure potentially reversible.
The technology has completed clinical trials and has demonstrated more than 99 per cent effectiveness in preventing pregnancies, without serious reported side effects. The documentary, Give It a Shot, does an excellent job of following the development and progress of this concept, which has been described as the first major new approach to male contraception in nearly 200 years.
The film strikes a balance between a lighthearted presentation and the seriousness of its subject. It takes viewers into the laboratories where scientists conducted in-vitro studies and cellular imaging, allowing them to observe how the technology works. It also explores the settings in which the technology underwent further validation and features intimate conversations with couples who participated in the clinical trials.
During my undergraduate years, I also had the opportunity to volunteer with an industry mentor, D.L. Pandya, at medical device conferences in Ahmedabad, Gujarat. He regularly invited medical technology pioneers from across India, including Dr. Guha, to these gatherings. This was also a period when Stanford's Biodesign Initiative was gaining momentum in India. Such experiences helped me understand that building an effective ecosystem connecting laboratory research with clinical application is just as important as developing the innovation itself.
An invention can be scientifically promising, but its journey from the laboratory to widespread clinical use requires sustained institutional support, regulatory progress, investment and public awareness. The success of any medical technology ultimately depends not only on its scientific merits but also on its accessibility and adoption.
I hope Give It a Shot brings greater public attention to this remarkable Indian innovation and provides the impetus needed to accelerate its wider adoption. A technology with the potential to expand contraceptive choices and contribute to greater gender equity deserves serious attention.
---
*R&D engineer based in Los Angeles

Comments

TRENDING

How strategic is India's commercial expansion in the Mediterranean?

By Vijay Prashad  On 26 October 2026, Greece’s foreign minister George Gerapetritis stood at the United Nations headquarters and rejected the maritime agreement between Turkey and Libya. Gerapetritis spoke on behalf of Greece of course, but also Bahrain, Cyprus, Egypt, the European Union, and the United Arab Emirates. Five days later, the Indian frigate INS Trishul entered Souda Bay in Crete as part of activities with the US Navy installation (Naval Support Activity) and with the NATO Maritime Interdiction Operational Training Centre. The sequence illuminates a developing strategic geography: India’s naval reach, its confrontation with Pakistan’s new Turkish partner, and its ambition to connect Indian capital to European markets increasingly converge in the eastern Mediterranean.

India among targets as China-linked hackers 'exploit' VPNs, firewalls

Counterview News   Cyberattackers grew faster and harder to detect in 2025, increasingly slipping through trusted systems rather than breaking in with obvious malware, claims U.S.-based  cybersecurity technology company CrowdStrike's 2026 Global Threat Report . The report says adversaries "grew more evasive than ever before," exploiting trust in supply chain partners, legitimate software, internal systems and employees. CrowdStrike now tracks 281 adversaries after naming 24 new ones in 2025, plus 150 activity clusters and emerging threat groups.

Reversal of the 'Howdy, Modi' wave: How the Indian diaspora stood in the 2026 midterms

  ​By Rajiv Shah  ​Returning from the United States on October 30—less than a week before the outcome of one of the world’s most closely watched elections—it seemed clear to me that the Indian diaspora had little love left for President Donald Trump . What I observed on the ground felt like a total reversal of Prime Minister Narendra Modi ’s 2019 pitch to NRIs in Houston: " Abki baar, Trump sarkar ."